Provided by Tiger Trade Technology Pte. Ltd.

Tevogen Bio Holdings

6.89
+0.14002.07%
Pre-market: 6.60-0.2900-4.21%08:07 EDT
Volume:3K
Turnover:17.76K
Market Cap:44.86M
PE:-1.09
High:6.93
Open:6.55
Low:6.55
Close:6.75
52wk High:49.50
52wk Low:3.64
Shares:6.51M
Float Shares:3.74M
Volume Ratio:0.51
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.3221
EPS(LYR):-8.0804
ROE:--
ROA:-297.37%
PB:-2.54
PE(LYR):-0.85

Loading ...

Tevogen Bio Holdings Q1 EPS $(1.61) Beats $(2.50) Estimate

Benzinga Earnings
·
May 16

Tevogen Bio Q1 FY26 net loss narrows 47.47% to $5.45 million

Reuters
·
May 16

Tevogen Bio Holdings Inc trading resumes

TIPRANKS
·
May 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:45 AM

Reuters
·
May 12

Tevogen Announces $3 Million Private Investment at $8 per Share, a 14% Premium From Latest Market Close

THOMSON REUTERS
·
May 12

Tevogen Bio Holdings Inc - Announces $3 Mln Pipe Financing With the Patel Family, Llp

THOMSON REUTERS
·
May 12

Press Release: Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

Dow Jones
·
May 12

Tevogen Bio prices USD 3 million PIPE at USD 8 per share premium

Reuters
·
May 12

Tevogen says PredicTcell training nears completion, precision improves about 10%

Reuters
·
Apr 27

Tevogen Bio gets Nasdaq notice for failing $50 million market value requirement

Reuters
·
Apr 23

Tevogen Bio FY25 net loss widens to $26.3 million

Reuters
·
Apr 01

BRIEF-Tevogen Advances Strategic CRO Evaluation To Expand Clinical Research Delivery Capabilities And Drive Revenue Growth

Reuters
·
Mar 27

Tevogen Bio Holdings: Opportunity Expected to Contribute More Than $20 Mln in Annual Revenue While Supporting Double-Digit Growth Beginning Next Year

THOMSON REUTERS
·
Mar 27

Tevogen Advances Strategic Cro Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

THOMSON REUTERS
·
Mar 27

Tevogen Bio implements 1-for-50 reverse stock split; Nasdaq bid-price compliance returns

Reuters
·
Mar 26

Tevogen Bio Regains Compliance With Nasdaq Listing Rule

MT Newswires Live
·
Mar 26

Tevogen regains compliance with Nasdaq minimum bid price requirement

TIPRANKS
·
Mar 26

Tevogen Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
Mar 26

Tevogen Bio Holdings Inc expected to post a loss of $2.00 a share - Earnings Preview

Reuters
·
Mar 24

Tevogen CIO Mittul Mehta to Speak at Microsoft Fabric Community Conference FabCon 2026

Reuters
·
Mar 19